Avid bioservices to report financial results for quarter and fiscal year ended april 30, 2023 after market close on june 21, 2023

Tustin, calif., june 14, 2023 (globe newswire) -- avid bioservices, inc. (nasdaq:cdmo), a dedicated biologics contract development and manufacturing organization (cdmo) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year ended april 30, 2023 on june 21, 2023, after market close and will host a webcast at 1:30 pm pacific time (4:30 pm eastern time). members of avid's senior management will discuss financial results for the quarter and fiscal year ended april 30, 2023, and review recent corporate developments.
CDMO Ratings Summary
CDMO Quant Ranking